| Name | Title | Contact Details |
|---|---|---|
Bijendra Malik |
Chief Information Security Officer | Profile |
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
Bristol Meyers Squibb Company is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clinical DataFax Systems, Inc. is a Hamilton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Corden Pharma Colorado is a Boulder, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
On the Forefront of COVID-19 Recognized leader in the COVID-19 field by governmental and non-governmental organizations as the reference assay...